Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    " October 23, 2013":" November 22, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" October 23, 2013":" November 22, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
PENTA15: Pharmacokinetic Study of Once Versus Twice Daily Abacavir in HIV-1 Infected Children Aged 3 to <36 Months
Condition: HIV Infection
Interventions: Other: Intervention 1: PK assessment while on Twice Daily Abacavir;   Other: Intervention 2: PK assessment while on Once Daily Abacavir
2 Withdrawn Safety, Tolerability, Drug Interactions, and Antiviral Activity of Rilpivirine in Antiretroviral-Naive HIV-Infected Children Less Than 12 Years of Age
Condition: HIV Infections
Intervention: Drug: Rilpivirine
3 Completed Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children
Condition: HIV Infection
Interventions: Drug: ABC Twice Daily;   Drug: ABC Once Daily;   Drug: 3TC Once Daily;   Drug: 3TC Twice Daily
4 Completed Pre-ART Retention in Care in Tanzania
Conditions: HIV (Human Immunodeficiency Virus);   AIDS (Acquired Immunodeficiency Syndrome)
Intervention:
5 Completed Multi-level Determinants of Starting ART Late: Aim 3
Conditions: Human Immunodeficiency Virus (HIV);   Acquired Immune Deficiency Syndrome (AIDS)
Intervention:
6 Active, not recruiting Barbershop Talk: HIV Prevention for African American Heterosexual Men
Condition: HIV
Interventions: Behavioral: BTWB intervention;   Behavioral: Cancer prevention and screening
7 Completed Safety and Efficacy Study of TwHF in HIV Patients With Poor Immune Responses
Condition: HIV
Interventions: Drug: Tripterygium Wilfordii Hook F extract (TwHF extract);   Drug: cART
8 Completed Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults
Conditions: HIV Infection;   Monoclonal Antibody, Human;   HIV Antibodies;   VRC01 Monoclonal Antibody;   Neutralizing Antibody
Intervention: Drug: VRC-HIVMAB060-00-AB
9 Completed Enhanced HIV Prevention in Couples: Feasibility Study #1
Conditions: Human Immunodeficiency Virus (HIV);   Acquired Immune Deficiency Syndrome (AIDS)
Intervention:
10 Completed Enhanced Prevention in Couples: Feasibility Study #2
Conditions: Human Immunodeficiency Virus (HIV);   Acquired Immune Deficiency Syndrome (AIDS)
Intervention: Other: Standard Counseling and Testing
11 Completed Multi-level Determinants of Starting ART Late: Aim 2
Conditions: Human Immunodeficiency Virus (HIV);   Acquired Immune Deficiency Syndrome (AIDS)
Intervention:
12 Completed Feasibility of an Exercise Intervention
Condition: HIV
Intervention: Other: HOME-EX
13 Recruiting Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers
Conditions: Healthy Volunteer;   HIV Vaccine
Interventions: Biological: Ad4-mgag;   Biological: Ad4-EnvC150
14 Completed Neurocognitive Effects and Tolerability of Efavirenz in Aging HIV-infected Individuals ("SHAC Neuro Study")
Conditions: HIV;   AIDS
Intervention: Behavioral: Neuropsychological testing
15 Completed Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring
Condition: HIV
Interventions: Drug: TDF Intravaginal Ring;   Drug: Placebo Intravaginal Ring
16 Completed A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04
Condition: HIV
Interventions: Drug: 1% vaginally applied tenofovir gel;   Drug: Tenofovir film- 10mg;   Drug: Tenofovir Film-40 mg;   Other: HEC Placebo Gel;   Other: Placebo Vaginal Film
17 Active, not recruiting Implementation of the Pre-Exposure Prophylaxis (PrEP) to HIV: A Demonstrative Project.
Condition: HIV
Intervention: Drug: emtricitabine / tenofovir 200/300 mg
18 Unknown  Modified Directly Observed Antiretroviral Therapy
Condition: HIV
Intervention: Other: Home visits
19 Completed Study to Evaluate the Effect of GSK1265744 on Cardiac Conduction
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1265744;   Drug: GSK1265744 matching placebo;   Drug: Moxifloxacin
20 Active, not recruiting Adherence to HIV Therapy in Heroin Addicts: Oral vs. Extended Release Naltrexone
Condition: HIV+
Interventions: Drug: Oral naltrexone;   Drug: Naltrexone implant

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.